7H-吡咯并[2,3-D]嘧啶-5-甲酸 、 肼基甲酸苄酯 以the title compound (yield 83%) was obtained as colorless crystals的产率得到benzyl 2-(7H-pyrrolo[2,3-d]pyrimidin-4-ylcarbonyl)hydrazinecarboxylate
For the purpose of providing a GSK-3β inhibitor containing an oxadiazole compound or a salt thereof or a prodrug thereof useful as an agent for the prophylaxis or treatment of a GSK-3β-related pathology or disease, the present invention provides a GSK-3β inhibitor containing a compound represented by the formula (I):
wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof.
For the purpose of providing a GSK-3β inhibitor containing an oxadiazole compound or a salt thereof or a prodrug thereof useful as an agent for the prophylaxis or treatment of a GSK-3β-related pathology or disease, the present invention provides a GSK-3β inhibitor containing a compound represented by the formula (I):
wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof.